Moderna stock jumps 4.5% as the FDA grants full approval for its COVID-19 vaccine in high-risk individuals aged six months to ...

A Qatar-based study involving 121,700 patients has underscored the importance of the post-vaccination monitoring to optimise ...

Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...

FDA head Marty Makary said the agency may fast-track drugs from companies that “equalize” the cost of medicines between the U ...

Last month, during Cannes Lions, Netflix announced that its ad inventory will be available to buy programmatically via Yahoo ...

A Wall Street maxim states, “Twenty percent of investors who want to make money are in stocks, while the other 80 percent who ...

Ursula von der Leyen, the EU’s most powerful official, coasted to victory after a no-confidence vote on Thursday. Some of her ...

A nurse who helped lead early clinical trials of Viagra and later played a key role in the Covid-19 research response speaks ...

Cypriot members of the European parliament were evenly split over a no-confidence vote in European Commission President Ursula von der Leyen, with two voting in favour, two voting against, and two not ...

Buying shares of beaten-down companies only makes sense if there are good reasons to expect them to bounce back. If that's not the case, stocks that may look cheap and attractive ...

This week’s motion of censure against President Ursula von der Leyen’s Commission was not about vaccines but rather a proxy ...

BRUSSELS -- European Commission President Ursula von der Leyen comfortably survived a vote of no confidence on Thursday as an ...